MVD

UniProt ID: P53602
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

MVD is human diphosphomevalonate decarboxylase (mevalonate-5-diphosphate decarboxylase; EC 4.1.1.33), the enzyme that catalyses the final step of the mevalonate pathway. It performs the ATP-dependent decarboxylation of (R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl diphosphate (IPP), releasing CO2, ADP and inorganic phosphate. IPP is the fundamental five-carbon (C5) isoprenoid building block from which all downstream isoprenoids are assembled, so MVD sits at the point where the mevalonate pathway delivers activated isoprene units for sterol (cholesterol) biosynthesis and for the non-sterol isoprenoid branches (dolichol, ubiquinone, and the prenyl groups used in protein prenylation). The protein is a member of the GHMP kinase superfamily, binds ATP, and functions as a homodimer of ~43-kDa subunits. It is a soluble cytosolic enzyme. In humans, loss-of-function and missense variants in MVD (together with MVK, the two principal porokeratosis genes) cause porokeratosis (POROK7), a disorder of faulty epidermal keratinization characterised by the cornoid lamella.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004163 diphosphomevalonate decarboxylase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Core catalytic molecular function of MVD, propagated by phylogenetic inference across the diphosphomevalonate decarboxylase family and strongly corroborated by direct human experimental evidence.
Reason: This is the defining molecular function of MVD (EC 4.1.1.33): ATP-dependent decarboxylation of (R)-5-diphosphomevalonate to isopentenyl diphosphate. The IBA is consistent with human biochemical and structural characterization.
Supporting Evidence:
PMID:18823933
Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
file:human/MVD/MVD-uniprot.txt
Catalyzes the ATP dependent decarboxylation of (R)-5-
GO:0019287 isopentenyl diphosphate biosynthetic process, mevalonate pathway
IBA
GO_REF:0000033
ACCEPT
Summary: Precise biological process for MVD: it produces isopentenyl diphosphate (IPP) as the final step of the mevalonate pathway.
Reason: MVD's product is IPP, and the enzyme catalyses the terminal mevalonate-pathway step that generates it. This term captures the direct biological process at the correct level of specificity and is the best core BP term.
Supporting Evidence:
PMID:18823933
catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
file:human/MVD/MVD-uniprot.txt
Functions in CC the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)
GO:0005829 cytosol
IBA
GO_REF:0000033
ACCEPT
Summary: MVD is a soluble cytosolic enzyme; the phylogenetically inferred cytosolic localization matches direct human experimental evidence.
Reason: Direct subcellular fractionation, immunofluorescence and immunoelectron microscopy established a cytosolic localization for human MVD, with no peroxisomal signal.
Supporting Evidence:
PMID:14972328
We found a cytosolic localization for both endogenous human mevalonate pyrophosphate decarboxylase
GO:0004163 diphosphomevalonate decarboxylase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (ARBA/InterPro/RHEA/EC) assignment of the core catalytic function, redundant with the experimental and IBA annotations.
Reason: Correctly maps the specific diphosphomevalonate decarboxylase activity (EC 4.1.1.33, RHEA:23732) to MVD; concordant with experimental evidence.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
EC=4.1.1.33
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: Broader cytoplasmic localization from the UniProt subcellular-location mapping; correct but less specific than cytosol.
Reason: UniProt annotates MVD as cytoplasmic, consistent with its established cytosolic localization. This parent term is correct though the more specific GO:0005829 (cytosol) is preferred.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm
GO:0005829 cytosol
IEA
GO_REF:0000120
ACCEPT
Summary: Automated cytosol localization consistent with experimental evidence.
Reason: Correct; MVD is cytosolic (established experimentally in PMID:14972328).
Supporting Evidence:
PMID:14972328
but no indication for a peroxisomal localization
GO:0008299 isoprenoid biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: Broader isoprenoid biosynthesis framing; MVD produces IPP, the universal isoprenoid precursor.
Reason: True but general parent of the more precise GO:0019287. Retained as an accurate higher-level BP: MVD's product IPP is the substrate for all isoprenoid biosynthesis.
Supporting Evidence:
PMID:18823933
The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA.
GO:0016831 carboxy-lyase activity
IEA
GO_REF:0000002
MODIFY
Summary: Broad InterPro2GO molecular-function parent of the specific diphosphomevalonate decarboxylase activity.
Reason: MVD is a decarboxylase (carboxy-lyase), so this term is not wrong, but it is an uninformative parent of the specific GO:0004163 diphosphomevalonate decarboxylase activity which is experimentally established. Replace with the specific term.
Supporting Evidence:
PMID:18823933
catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
GO:0019287 isopentenyl diphosphate biosynthetic process, mevalonate pathway
IEA
GO_REF:0000002
ACCEPT
Summary: Automated (InterPro2GO) assignment of the precise mevalonate-pathway IPP biosynthesis process, redundant with the IBA.
Reason: Correct and specific; MVD produces IPP as the terminal mevalonate-pathway step.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
Functions in CC the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)
GO:0006695 cholesterol biosynthetic process
IEA
GO_REF:0000041
KEEP AS NON CORE
Summary: UniPathway-derived link to cholesterol biosynthesis. MVD feeds the sterol branch but its direct product is IPP, upstream of the sterol/non-sterol branch point.
Reason: Cholesterol biosynthesis is a downstream consequence of MVD activity rather than its direct process: MVD makes IPP, which supplies both sterol (cholesterol) and many non-sterol isoprenoid branches (dolichol, ubiquinone, prenyl groups). The accurate direct BP is the mevalonate-pathway IPP biosynthesis (GO:0019287). Retain as a valid non-core downstream pathway association.
Supporting Evidence:
file:human/MVD/MVD-uniprot.txt
a key precursor for the biosynthesis of isoprenoids and sterol
file:human/MVD/MVD-uniprot.txt
PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.
GO:0005737 cytoplasm
IDA
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in...
ACCEPT
Summary: Experimental cytoplasmic/cytosolic localization of human MVD.
Reason: Directly supported by the localization study; MVD is active in the cytosol (cytoplasm). GO:0005829 (cytosol) is the more specific form of the same finding.
Supporting Evidence:
PMID:14972328
We found a cytosolic localization for both endogenous human mevalonate pyrophosphate decarboxylase
GO:0004163 diphosphomevalonate decarboxylase activity
EXP
PMID:18823933
Human mevalonate diphosphate decarboxylase: characterization...
ACCEPT
Summary: Direct experimental characterization of recombinant human MVD's diphosphomevalonate decarboxylase activity, including kinetics and active-site mutagenesis, backed by a crystal structure.
Reason: Gold-standard experimental support for the core catalytic function. Kinetic parameters were measured and active-site residues (R161, N17) validated; R161Q causes ~1000-fold loss of activity.
Supporting Evidence:
PMID:18823933
Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
PMID:18823933
R161Q exhibits a approximately 1000-fold diminution in specific activity
GO:0004163 diphosphomevalonate decarboxylase activity
EXP
PMID:8626466
Molecular cloning and expression of the cDNAs encoding human...
ACCEPT
Summary: Cloning/expression paper showing recombinant human MVD has decarboxylase activity (2.4 units/mg).
Reason: Experimental confirmation of the core catalytic function; duplicate of the other GO:0004163 catalytic annotations.
Supporting Evidence:
PMID:8626466
The recombinant human enzyme is a homodimer of 43-kDa subunits with a specific activity of 2.4 units/mg.
GO:0004163 diphosphomevalonate decarboxylase activity
EXP
PMID:9392419
Post-translational regulation of mevalonate kinase by interm...
ACCEPT
Summary: Recombinant human MDDase (MVD) was expressed, purified and assayed as part of a mevalonate-pathway feedback-inhibition study.
Reason: Experimental support for the decarboxylase activity; MVD's KM for (R)-5-diphosphomevalonate was determined. Duplicate of the core catalytic annotation.
Supporting Evidence:
PMID:9392419
mevalonate diphosphate decarboxylase (MDDase)
file:human/MVD/MVD-uniprot.txt
KM=7.4 uM for (R)-5-diphosphomevalonate {ECO:0000269|PubMed:9392419}
GO:0005829 cytosol
TAS
Reactome:R-HSA-1655836
ACCEPT
Summary: Reactome traceable assertion placing MVD in the cytosol.
Reason: Consistent with the experimentally established cytosolic localization of MVD.
Supporting Evidence:
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in the cytosol.
GO:0005829 cytosol
TAS
Reactome:R-HSA-191414
ACCEPT
Summary: Reactome traceable assertion (MVD decarboxylates MVA5PP to IPPP reaction) placing MVD in the cytosol.
Reason: Consistent with the experimentally established cytosolic localization; the cited Reactome reaction is exactly the MVD decarboxylation of mevalonate-5-diphosphate to IPP.
Supporting Evidence:
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in the cytosol.
GO:0004163 diphosphomevalonate decarboxylase activity
IDA
PMID:11792727
Absence of functional peroxisomes does not lead to deficienc...
ACCEPT
Summary: MVD (MPD) decarboxylase activity measured directly in human/mouse tissue in a study of MVA-pathway enzyme activities.
Reason: Direct activity measurement of MVD supports the core catalytic function (duplicate of the other GO:0004163 annotations).
Supporting Evidence:
PMID:11792727
mislocalization of enzymes to the cytosol does not lead to decreased activity or
GO:0004163 diphosphomevalonate decarboxylase activity
IDA
PMID:14680974
Cholesterol biosynthesis is not defective in peroxisome biog...
ACCEPT
Summary: MVD (mevalonate pyrophosphate decarboxylase) activity measured directly among presqualene MVA/isoprenoid enzymes in PBD fibroblasts.
Reason: Direct activity measurement supports the core catalytic function (duplicate of the other GO:0004163 annotations).
Supporting Evidence:
PMID:14680974
mevalonate pyrophosphate decarboxylase
GO:0006695 cholesterol biosynthetic process
NAS
PMID:14680974
Cholesterol biosynthesis is not defective in peroxisome biog...
KEEP AS NON CORE
Summary: Author-stated (NAS) placement of MVD in the cholesterol/isoprenoid biosynthetic pathway.
Reason: MVD is one of the presqualene enzymes of the cholesterol/isoprenoid pathway, but cholesterol synthesis is downstream of MVD's direct product IPP (which also feeds non-sterol branches). Accurate as a non-core downstream pathway association; the precise direct BP is the mevalonate-pathway IPP biosynthesis.
Supporting Evidence:
PMID:14680974
five different enzymes of the presqualene segment of the cholesterol/isoprenoid biosynthetic pathway
GO:0008284 positive regulation of cell population proliferation
IMP
PMID:9270019
Regulation of proliferation and Ras localization in transfor...
KEEP AS NON CORE
Summary: Inhibiting MVD with 6-fluoromevalonate (Fmev) blocks production of downstream mevalonate products, prevents Ras prenylation/membrane localization, and suppresses proliferation of transformed cells.
Reason: This is a pathway-level, indirect effect: MVD activity is required to make IPP and hence the prenyl groups that drive Ras-dependent proliferation. It reflects a physiological consequence of MVD's metabolic role rather than a distinct signalling function of the protein. Retain as a non-core process rather than a core molecular function. Per curation policy this experimental (IMP) annotation is not removed.
Supporting Evidence:
PMID:9270019
6-fluoromevalonate (Fmev), an inhibitor of diphosphomevalonate decarboxylase
PMID:9270019
completely prevented the proliferation of U-937 cells
GO:0008299 isoprenoid biosynthetic process
IDA
PMID:11792727
Absence of functional peroxisomes does not lead to deficienc...
ACCEPT
Summary: Experimental support for MVD participation in isoprenoid/cholesterol biosynthesis (MVA-pathway enzyme activities measured).
Reason: Broad but accurate: MVD produces IPP, the universal isoprenoid precursor. GO:0019287 is the more precise BP; this parent is retained as correct.
Supporting Evidence:
PMID:11792727
enzymes involved in cholesterol biosynthesis
GO:0008299 isoprenoid biosynthetic process
IDA
PMID:14680974
Cholesterol biosynthesis is not defective in peroxisome biog...
ACCEPT
Summary: Experimental support for MVD participation in the cholesterol/isoprenoid biosynthetic pathway.
Reason: Accurate higher-level BP; MVD's product IPP is the isoprenoid building block. GO:0019287 is the precise process; this parent is retained as correct.
Supporting Evidence:
PMID:14680974
cholesterol/isoprenoid biosynthetic pathway
GO:0030544 Hsp70 protein binding
IPI
PMID:12646231
Mortalin-MPD (mevalonate pyrophosphate decarboxylase) intera...
MARK AS OVER ANNOTATED
Summary: MVD (MPD) was identified in a yeast two-hybrid screen and co-IP as an interactor of mortalin (mot-2/GRP75), a member of the HSP70 family, in a study of proliferation control.
Reason: A physical interaction with an HSP70-family chaperone (mortalin) is a protein-binding-type annotation that does not describe MVD's core catalytic molecular function; it is peripheral to why MVD exists (isoprenoid synthesis). Per curation policy this experimental (IPI) annotation is not removed but is flagged as an over-annotation relative to the enzyme's function.
Supporting Evidence:
PMID:12646231
Mevalonate pyrophosphate decarboxylase (MPD) was identified as one of the mortalin binding partners
GO:0042803 protein homodimerization activity
IDA
PMID:8626466
Molecular cloning and expression of the cDNAs encoding human...
KEEP AS NON CORE
Summary: Recombinant human MVD is a homodimer of ~43-kDa subunits.
Reason: Homodimerization is an experimentally supported structural property of the enzyme (also stated as SUBUNIT: Homodimer in UniProt), but it is a quaternary structure feature rather than MVD's core catalytic function. Retain as non-core.
Supporting Evidence:
PMID:8626466
The recombinant human enzyme is a homodimer of 43-kDa subunits
file:human/MVD/MVD-uniprot.txt
SUBUNIT: Homodimer.
GO:0005777 peroxisome
IDA NOT
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in...
ACCEPT
Summary: MVD is explicitly NOT located in the peroxisome; earlier peroxisomal claims were refuted by direct localization studies.
Reason: The negated annotation is correct and important: careful subcellular fractionation and microscopy found no peroxisomal MVD, overturning earlier reports of a peroxisomal targeting signal. UniProt records the same correction in its CAUTION note.
Supporting Evidence:
PMID:14972328
but no indication for a peroxisomal localization
file:human/MVD/MVD-uniprot.txt
However, was later shown to be cytosolic
GO:0005829 cytosol
IDA
PMID:14972328
Human mevalonate pyrophosphate decarboxylase is localized in...
ACCEPT
Summary: Direct experimental evidence that human MVD is a cytosolic protein.
Reason: The definitive localization study; MVD is cytosolic in fibroblasts, liver, CV1 and HEK293 cells by fractionation, immunofluorescence and immunoelectron microscopy.
Supporting Evidence:
PMID:14972328
We found a cytosolic localization for both endogenous human mevalonate pyrophosphate decarboxylase

Core Functions

ATP-dependent decarboxylation of (R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl diphosphate (IPP), CO2, ADP and phosphate, the final step of the mevalonate pathway that generates the universal C5 isoprenoid unit.

Supporting Evidence:
  • PMID:18823933
    Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate
  • file:human/MVD/MVD-uniprot.txt
    Catalyzes the ATP dependent decarboxylation of (R)-5-

As the terminal mevalonate-pathway enzyme, MVD supplies IPP for the broader isoprenoid biosynthetic program (sterols and non-sterol isoprenoids), acting as a soluble cytosolic enzyme.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:18823933
    The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA.
  • PMID:14972328
    We found a cytosolic localization for both endogenous human mevalonate pyrophosphate decarboxylase

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniPathway vocabulary mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Combined Automated Annotation using Multiple IEA Methods
file:human/MVD/MVD-uniprot.txt
UniProtKB entry P53602 (MVD1_HUMAN), Diphosphomevalonate decarboxylase
Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis.
Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their role in control of cellular proliferation.
Cholesterol biosynthesis is not defective in peroxisome biogenesis defective fibroblasts.
Human mevalonate pyrophosphate decarboxylase is localized in the cytosol.
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
Molecular cloning and expression of the cDNAs encoding human and yeast mevalonate pyrophosphate decarboxylase.
Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways.
Reactome:R-HSA-1655836
Expression of Diphosphomevalonate Decarboxylase (MVD)
Reactome:R-HSA-191414
MVD decarboxylates MVA5PP to IPPP

Suggested Questions for Experts

Q: Beyond its metabolic role, does the MVD-mortalin (HSP70) interaction have a regulatory function on MVD stability or activity, or is it primarily relevant to mortalin-controlled proliferation?

Suggested Experiments

Experiment: Structure-guided kinetic characterization of the full panel of POROK7 missense variants to quantify how each affects diphosphomevalonate decarboxylase activity and homodimer stability, correlating biochemical severity with clinical presentation.

📚 Additional Documentation

Notes

(MVD-notes.md)

MVD (Diphosphomevalonate decarboxylase) — review notes

UniProtKB: P53602 (MVD1_HUMAN), gene MVD (synonym MPD). 400 aa, ~43 kDa subunit. HGNC:7529.

Core function

MVD catalyses the final step of the mevalonate (MVA) pathway: the ATP-dependent
decarboxylation of (R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl
diphosphate (IPP) + CO2 (+ ADP + Pi). EC 4.1.1.33; RHEA:23732.

  • [file:human/MVD/MVD-uniprot.txt "Catalyzes the ATP dependent decarboxylation of (R)-5-diphosphomevalonate to form isopentenyl diphosphate (IPP)"]
  • PMID:18823933
  • Reaction (UniProt): (R)-5-diphosphomevalonate + ATP = isopentenyl diphosphate + ADP + CO2 + phosphate.

IPP is the fundamental C5 isoprenoid building block; this reaction feeds sterol
(cholesterol) and non-sterol isoprenoid biosynthesis (dolichol, ubiquinone, prenyl
groups for protein prenylation).
- PMID:18823933

Structure / family

  • GHMP kinase superfamily member. PMID:18823933
  • Homodimer of ~43-kDa subunits. PMID:8626466 Also UniProt SUBUNIT: Homodimer.
  • Crystal structure 3D4J (2.4 Å); R161 and N17 are active-site residues important for binding/orientation of mevalonate diphosphate. R161Q ~1000-fold loss of activity. PMID:18823933
  • ATP-binding (KW: ATP-binding; Nucleotide-binding). [file:human/MVD/MVD-uniprot.txt "F:ATP binding; IEA:UniProtKB-KW"]

Localization

  • Cytosolic. Earlier claims of peroxisomal targeting were refuted.
  • PMID:14972328
  • UniProt CAUTION: "Was originally thought to be located in the peroxisome (PubMed:11108725). However, was later shown to be cytosolic (PubMed:14972328)."
  • GOA carries a NOT located_in peroxisome (IDA, PMID:14972328) — consistent.

Disease

  • Porokeratosis 7, multiple types (POROK7; MIM:614714), a disorder of faulty
    keratinization (cornoid lamella). MVD and MVK are the principal porokeratosis genes.
    Many POROK7 missense variants; R161Q abolishes decarboxylase activity.
    [PMID:26202976 — "Genomic variations of the mevalonate pathway in porokeratosis"]
    (variant paper; also UniProt DISEASE + VARIANT annotations)

Notes on specific annotations

  • Multiple EXP/IDA GO:0004163 annotations (PMID:18823933, 8626466, 9392419, 11792727,
    14680974) — core catalytic function, all ACCEPT (one as core, rest KEEP_AS_NON_CORE
    duplicates).
  • GO:0008299 isoprenoid biosynthetic process — the enzyme's product IPP is the isoprenoid
    precursor; ACCEPT as a broader BP framing. GO:0019287 (isopentenyl diphosphate
    biosynthetic process, mevalonate pathway) is the precise BP — core.
  • GO:0006695 cholesterol biosynthetic process (NAS/IEA UniPathway) — MVA pathway feeds
    cholesterol synthesis but MVD is upstream of the sterol branch point; the direct product
    is IPP, and IPP also feeds non-sterol isoprenoids. Cholesterol is a downstream
    consequence, not MVD's direct BP. KEEP_AS_NON_CORE (over-specific; the mevalonate/IPP
    BP is the accurate direct process).
  • GO:0016831 carboxy-lyase activity (IEA, InterPro) — true but a broad parent of the
    specific GO:0004163; MODIFY toward the specific term (or accept as broader). Marked as
    over-annotated/parent; propose replacement GO:0004163.
  • GO:0030544 Hsp70 protein binding (IPI, PMID:12646231) — mortalin (mot-2/GRP75, HSP70
    family) interaction from a Y2H screen; bare protein-binding-type MF, not the core
    catalytic function. Per policy, do NOT REMOVE an experimental IPI whose full text is
    unverified → MARK_AS_OVER_ANNOTATED.
  • GO:0042803 protein homodimerization activity (IDA, PMID:8626466) — supported (homodimer),
    KEEP_AS_NON_CORE.
  • GO:0008284 positive regulation of cell population proliferation (IMP, PMID:9270019) —
    the paper shows Fmev (an MVD inhibitor) blocks proliferation via loss of downstream
    prenylated Ras; this is an indirect pathway-level effect (mevalonate products drive
    proliferation), not a distinct MVD signalling function. KEEP_AS_NON_CORE.
  • Localization terms: cytosol (GO:0005829) ACCEPT; cytoplasm (GO:0005737) ACCEPT as
    broader parent; NOT peroxisome ACCEPT (correct negation).

Provenance

Deep research provider (falcon) was out of credits (HTTP 402) at review time; no
-deep-research-falcon.md generated. Review grounded in MVD-uniprot.txt, seeded GOA, and
cached publications/PMID_*.md (all 8 cited PMIDs present).

📄 View Raw YAML

id: P53602
gene_symbol: MVD
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  MVD is human diphosphomevalonate decarboxylase (mevalonate-5-diphosphate
  decarboxylase; EC 4.1.1.33), the enzyme that catalyses the final step of the
  mevalonate pathway. It performs the ATP-dependent decarboxylation of
  (R)-5-diphosphomevalonate (mevalonate-5-diphosphate) to isopentenyl
  diphosphate (IPP), releasing CO2, ADP and inorganic phosphate. IPP is the
  fundamental five-carbon (C5) isoprenoid building block from which all
  downstream isoprenoids are assembled, so MVD sits at the point where the
  mevalonate pathway delivers activated isoprene units for sterol (cholesterol)
  biosynthesis and for the non-sterol isoprenoid branches (dolichol, ubiquinone,
  and the prenyl groups used in protein prenylation). The protein is a member of
  the GHMP kinase superfamily, binds ATP, and functions as a homodimer of
  ~43-kDa subunits. It is a soluble cytosolic enzyme. In humans, loss-of-function
  and missense variants in MVD (together with MVK, the two principal
  porokeratosis genes) cause porokeratosis (POROK7), a disorder of faulty
  epidermal keratinization characterised by the cornoid lamella.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: file:human/MVD/MVD-uniprot.txt
  title: UniProtKB entry P53602 (MVD1_HUMAN), Diphosphomevalonate decarboxylase
  findings: []
- id: PMID:11792727
  title: Absence of functional peroxisomes does not lead to deficiency of enzymes
    involved in cholesterol biosynthesis.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Shows MVD (and other MVA-pathway enzymes) retain activity in
      peroxisome-deficient cells; supports cytosolic function, not a specific catalytic
      characterization of MVD.
- id: PMID:12646231
  title: Mortalin-MPD (mevalonate pyrophosphate decarboxylase) interactions and their
    role in control of cellular proliferation.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: Yeast two-hybrid / co-IP interaction between MPD (MVD) and mortalin
      (mot-2/GRP75, an HSP70-family protein). Supports the Hsp70-binding IPI but this
      is an interaction finding, not MVD's core molecular function.
- id: PMID:14680974
  title: Cholesterol biosynthesis is not defective in peroxisome biogenesis defective
    fibroblasts.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Measures MVD (MPD) activity among five presqualene MVA/isoprenoid
      enzymes in PBD fibroblasts; supports enzymatic activity and cytosolic function.
- id: PMID:14972328
  title: Human mevalonate pyrophosphate decarboxylase is localized in the cytosol.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Definitive subcellular localization study; MVD is cytosolic with no
      peroxisomal localization. Directly supports the cytosol/NOT-peroxisome annotations.
- id: PMID:18823933
  title: 'Human mevalonate diphosphate decarboxylase: characterization, investigation
    of the mevalonate diphosphate binding site, and crystal structure.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Full text available. Recombinant human MDD characterization, kinetics,
      active-site mutagenesis (R161, N17) and 2.4 A crystal structure (3D4J). Directly
      establishes the diphosphomevalonate decarboxylase activity and reaction.
- id: PMID:8626466
  title: Molecular cloning and expression of the cDNAs encoding human and yeast mevalonate
    pyrophosphate decarboxylase.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Cloning and expression of human MVD; recombinant enzyme is a homodimer
      of 43-kDa subunits with measurable decarboxylase activity. Supports catalytic
      activity and homodimerization.
- id: PMID:9270019
  title: Regulation of proliferation and Ras localization in transformed cells by
    products of mevalonate metabolism.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Uses 6-fluoromevalonate (Fmev, an MVD inhibitor) to block downstream
      mevalonate products and Ras prenylation, suppressing proliferation. Supports a
      pathway-level role in proliferation but the effect is indirect (via prenylated
      products), not a direct MVD signalling function.
- id: PMID:9392419
  title: Post-translational regulation of mevalonate kinase by intermediates of the
    cholesterol and nonsterol isoprene biosynthetic pathways.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Expressed and assayed recombinant human MDDase (MVD) alongside MKase
      and PMKase; the focus is feedback inhibition of MKase, but MVD activity and
      kinetics (KM for mevalonate diphosphate) were determined. Supports catalytic
      activity.
- id: Reactome:R-HSA-1655836
  title: Expression of Diphosphomevalonate Decarboxylase (MVD)
  findings: []
- id: Reactome:R-HSA-191414
  title: MVD decarboxylates MVA5PP to IPPP
  findings: []
existing_annotations:
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Core catalytic molecular function of MVD, propagated by phylogenetic
      inference across the diphosphomevalonate decarboxylase family and strongly
      corroborated by direct human experimental evidence.
    action: ACCEPT
    reason: >-
      This is the defining molecular function of MVD (EC 4.1.1.33): ATP-dependent
      decarboxylation of (R)-5-diphosphomevalonate to isopentenyl diphosphate.
      The IBA is consistent with human biochemical and structural characterization.
    supported_by:
    - reference_id: PMID:18823933
      supporting_text: "Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "Catalyzes the ATP dependent decarboxylation of (R)-5-"
- term:
    id: GO:0019287
    label: isopentenyl diphosphate biosynthetic process, mevalonate pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Precise biological process for MVD: it produces isopentenyl diphosphate
      (IPP) as the final step of the mevalonate pathway.
    action: ACCEPT
    reason: >-
      MVD's product is IPP, and the enzyme catalyses the terminal mevalonate-pathway
      step that generates it. This term captures the direct biological process at
      the correct level of specificity and is the best core BP term.
    supported_by:
    - reference_id: PMID:18823933
      supporting_text: "catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "Functions in\nCC       the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      MVD is a soluble cytosolic enzyme; the phylogenetically inferred cytosolic
      localization matches direct human experimental evidence.
    action: ACCEPT
    reason: >-
      Direct subcellular fractionation, immunofluorescence and immunoelectron
      microscopy established a cytosolic localization for human MVD, with no
      peroxisomal signal.
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Automated (ARBA/InterPro/RHEA/EC) assignment of the core catalytic function,
      redundant with the experimental and IBA annotations.
    action: ACCEPT
    reason: >-
      Correctly maps the specific diphosphomevalonate decarboxylase activity
      (EC 4.1.1.33, RHEA:23732) to MVD; concordant with experimental evidence.
    supported_by:
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "EC=4.1.1.33"
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Broader cytoplasmic localization from the UniProt subcellular-location
      mapping; correct but less specific than cytosol.
    action: ACCEPT
    reason: >-
      UniProt annotates MVD as cytoplasmic, consistent with its established
      cytosolic localization. This parent term is correct though the more specific
      GO:0005829 (cytosol) is preferred.
    supported_by:
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "SUBCELLULAR LOCATION: Cytoplasm"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Automated cytosol localization consistent with experimental evidence.
    action: ACCEPT
    reason: >-
      Correct; MVD is cytosolic (established experimentally in PMID:14972328).
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "but no indication for a peroxisomal localization"
- term:
    id: GO:0008299
    label: isoprenoid biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: >-
      Broader isoprenoid biosynthesis framing; MVD produces IPP, the universal
      isoprenoid precursor.
    action: ACCEPT
    reason: >-
      True but general parent of the more precise GO:0019287. Retained as an
      accurate higher-level BP: MVD's product IPP is the substrate for all
      isoprenoid biosynthesis.
    supported_by:
    - reference_id: PMID:18823933
      supporting_text: "The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA."
- term:
    id: GO:0016831
    label: carboxy-lyase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Broad InterPro2GO molecular-function parent of the specific
      diphosphomevalonate decarboxylase activity.
    action: MODIFY
    reason: >-
      MVD is a decarboxylase (carboxy-lyase), so this term is not wrong, but it is
      an uninformative parent of the specific GO:0004163 diphosphomevalonate
      decarboxylase activity which is experimentally established. Replace with the
      specific term.
    proposed_replacement_terms:
    - id: GO:0004163
      label: diphosphomevalonate decarboxylase activity
    supported_by:
    - reference_id: PMID:18823933
      supporting_text: "catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
- term:
    id: GO:0019287
    label: isopentenyl diphosphate biosynthetic process, mevalonate pathway
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Automated (InterPro2GO) assignment of the precise mevalonate-pathway IPP
      biosynthesis process, redundant with the IBA.
    action: ACCEPT
    reason: >-
      Correct and specific; MVD produces IPP as the terminal mevalonate-pathway step.
    supported_by:
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "Functions in\nCC       the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP)"
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: >-
      UniPathway-derived link to cholesterol biosynthesis. MVD feeds the sterol
      branch but its direct product is IPP, upstream of the sterol/non-sterol
      branch point.
    action: KEEP_AS_NON_CORE
    reason: >-
      Cholesterol biosynthesis is a downstream consequence of MVD activity rather
      than its direct process: MVD makes IPP, which supplies both sterol
      (cholesterol) and many non-sterol isoprenoid branches (dolichol, ubiquinone,
      prenyl groups). The accurate direct BP is the mevalonate-pathway IPP
      biosynthesis (GO:0019287). Retain as a valid non-core downstream pathway
      association.
    supported_by:
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "a key precursor for the biosynthesis of isoprenoids and sterol"
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "PATHWAY: Steroid biosynthesis; cholesterol biosynthesis."
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:14972328
  qualifier: is_active_in
  review:
    summary: >-
      Experimental cytoplasmic/cytosolic localization of human MVD.
    action: ACCEPT
    reason: >-
      Directly supported by the localization study; MVD is active in the cytosol
      (cytoplasm). GO:0005829 (cytosol) is the more specific form of the same
      finding.
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: EXP
  original_reference_id: PMID:18823933
  qualifier: enables
  review:
    summary: >-
      Direct experimental characterization of recombinant human MVD's
      diphosphomevalonate decarboxylase activity, including kinetics and active-site
      mutagenesis, backed by a crystal structure.
    action: ACCEPT
    reason: >-
      Gold-standard experimental support for the core catalytic function. Kinetic
      parameters were measured and active-site residues (R161, N17) validated; R161Q
      causes ~1000-fold loss of activity.
    supported_by:
    - reference_id: PMID:18823933
      supporting_text: "Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
    - reference_id: PMID:18823933
      supporting_text: "R161Q exhibits a approximately \n1000-fold diminution in specific activity"
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: EXP
  original_reference_id: PMID:8626466
  qualifier: enables
  review:
    summary: >-
      Cloning/expression paper showing recombinant human MVD has decarboxylase
      activity (2.4 units/mg).
    action: ACCEPT
    reason: >-
      Experimental confirmation of the core catalytic function; duplicate of the
      other GO:0004163 catalytic annotations.
    supported_by:
    - reference_id: PMID:8626466
      supporting_text: "The recombinant human enzyme is a \nhomodimer of 43-kDa subunits with a specific activity of 2.4 units/mg."
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: EXP
  original_reference_id: PMID:9392419
  qualifier: enables
  review:
    summary: >-
      Recombinant human MDDase (MVD) was expressed, purified and assayed as part of
      a mevalonate-pathway feedback-inhibition study.
    action: ACCEPT
    reason: >-
      Experimental support for the decarboxylase activity; MVD's KM for
      (R)-5-diphosphomevalonate was determined. Duplicate of the core catalytic
      annotation.
    supported_by:
    - reference_id: PMID:9392419
      supporting_text: "mevalonate diphosphate decarboxylase (MDDase)"
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "KM=7.4 uM for (R)-5-diphosphomevalonate {ECO:0000269|PubMed:9392419}"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1655836
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assertion placing MVD in the cytosol.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally established cytosolic localization of MVD.
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "Human mevalonate pyrophosphate decarboxylase is localized in the \ncytosol."
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-191414
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assertion (MVD decarboxylates MVA5PP to IPPP reaction)
      placing MVD in the cytosol.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally established cytosolic localization; the
      cited Reactome reaction is exactly the MVD decarboxylation of
      mevalonate-5-diphosphate to IPP.
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "Human mevalonate pyrophosphate decarboxylase is localized in the \ncytosol."
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: IDA
  original_reference_id: PMID:11792727
  qualifier: enables
  review:
    summary: >-
      MVD (MPD) decarboxylase activity measured directly in human/mouse tissue in a
      study of MVA-pathway enzyme activities.
    action: ACCEPT
    reason: >-
      Direct activity measurement of MVD supports the core catalytic function
      (duplicate of the other GO:0004163 annotations).
    supported_by:
    - reference_id: PMID:11792727
      supporting_text: "mislocalization of enzymes to the cytosol does not lead to decreased activity or"
- term:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  evidence_type: IDA
  original_reference_id: PMID:14680974
  qualifier: enables
  review:
    summary: >-
      MVD (mevalonate pyrophosphate decarboxylase) activity measured directly among
      presqualene MVA/isoprenoid enzymes in PBD fibroblasts.
    action: ACCEPT
    reason: >-
      Direct activity measurement supports the core catalytic function (duplicate
      of the other GO:0004163 annotations).
    supported_by:
    - reference_id: PMID:14680974
      supporting_text: "mevalonate pyrophosphate decarboxylase"
- term:
    id: GO:0006695
    label: cholesterol biosynthetic process
  evidence_type: NAS
  original_reference_id: PMID:14680974
  qualifier: involved_in
  review:
    summary: >-
      Author-stated (NAS) placement of MVD in the cholesterol/isoprenoid
      biosynthetic pathway.
    action: KEEP_AS_NON_CORE
    reason: >-
      MVD is one of the presqualene enzymes of the cholesterol/isoprenoid pathway,
      but cholesterol synthesis is downstream of MVD's direct product IPP (which
      also feeds non-sterol branches). Accurate as a non-core downstream pathway
      association; the precise direct BP is the mevalonate-pathway IPP biosynthesis.
    supported_by:
    - reference_id: PMID:14680974
      supporting_text: "five different \nenzymes of the presqualene segment of the cholesterol/isoprenoid biosynthetic \npathway"
- term:
    id: GO:0008284
    label: positive regulation of cell population proliferation
  evidence_type: IMP
  original_reference_id: PMID:9270019
  qualifier: involved_in
  review:
    summary: >-
      Inhibiting MVD with 6-fluoromevalonate (Fmev) blocks production of downstream
      mevalonate products, prevents Ras prenylation/membrane localization, and
      suppresses proliferation of transformed cells.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is a pathway-level, indirect effect: MVD activity is required to make IPP
      and hence the prenyl groups that drive Ras-dependent proliferation. It reflects
      a physiological consequence of MVD's metabolic role rather than a distinct
      signalling function of the protein. Retain as a non-core process rather than a
      core molecular function. Per curation policy this experimental (IMP) annotation
      is not removed.
    supported_by:
    - reference_id: PMID:9270019
      supporting_text: "6-fluoromevalonate (Fmev), an inhibitor of diphosphomevalonate decarboxylase"
    - reference_id: PMID:9270019
      supporting_text: "completely \nprevented the proliferation of U-937 cells"
- term:
    id: GO:0008299
    label: isoprenoid biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:11792727
  qualifier: involved_in
  review:
    summary: >-
      Experimental support for MVD participation in isoprenoid/cholesterol
      biosynthesis (MVA-pathway enzyme activities measured).
    action: ACCEPT
    reason: >-
      Broad but accurate: MVD produces IPP, the universal isoprenoid precursor.
      GO:0019287 is the more precise BP; this parent is retained as correct.
    supported_by:
    - reference_id: PMID:11792727
      supporting_text: "enzymes \ninvolved in cholesterol biosynthesis"
- term:
    id: GO:0008299
    label: isoprenoid biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:14680974
  qualifier: involved_in
  review:
    summary: >-
      Experimental support for MVD participation in the cholesterol/isoprenoid
      biosynthetic pathway.
    action: ACCEPT
    reason: >-
      Accurate higher-level BP; MVD's product IPP is the isoprenoid building block.
      GO:0019287 is the precise process; this parent is retained as correct.
    supported_by:
    - reference_id: PMID:14680974
      supporting_text: "cholesterol/isoprenoid biosynthetic \npathway"
- term:
    id: GO:0030544
    label: Hsp70 protein binding
  evidence_type: IPI
  original_reference_id: PMID:12646231
  qualifier: enables
  review:
    summary: >-
      MVD (MPD) was identified in a yeast two-hybrid screen and co-IP as an
      interactor of mortalin (mot-2/GRP75), a member of the HSP70 family, in a study
      of proliferation control.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      A physical interaction with an HSP70-family chaperone (mortalin) is a
      protein-binding-type annotation that does not describe MVD's core catalytic
      molecular function; it is peripheral to why MVD exists (isoprenoid synthesis).
      Per curation policy this experimental (IPI) annotation is not removed but is
      flagged as an over-annotation relative to the enzyme's function.
    supported_by:
    - reference_id: PMID:12646231
      supporting_text: "Mevalonate pyrophosphate decarboxylase (MPD) was \nidentified as one of the mortalin binding partners"
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:8626466
  qualifier: enables
  review:
    summary: >-
      Recombinant human MVD is a homodimer of ~43-kDa subunits.
    action: KEEP_AS_NON_CORE
    reason: >-
      Homodimerization is an experimentally supported structural property of the
      enzyme (also stated as SUBUNIT: Homodimer in UniProt), but it is a quaternary
      structure feature rather than MVD's core catalytic function. Retain as non-core.
    supported_by:
    - reference_id: PMID:8626466
      supporting_text: "The recombinant human enzyme is a \nhomodimer of 43-kDa subunits"
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0005777
    label: peroxisome
  evidence_type: IDA
  original_reference_id: PMID:14972328
  qualifier: located_in
  negated: true
  review:
    summary: >-
      MVD is explicitly NOT located in the peroxisome; earlier peroxisomal claims
      were refuted by direct localization studies.
    action: ACCEPT
    reason: >-
      The negated annotation is correct and important: careful subcellular
      fractionation and microscopy found no peroxisomal MVD, overturning earlier
      reports of a peroxisomal targeting signal. UniProt records the same correction
      in its CAUTION note.
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "but no indication for a peroxisomal localization"
    - reference_id: file:human/MVD/MVD-uniprot.txt
      supporting_text: "However, was later shown to be cytosolic"
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: PMID:14972328
  qualifier: located_in
  review:
    summary: >-
      Direct experimental evidence that human MVD is a cytosolic protein.
    action: ACCEPT
    reason: >-
      The definitive localization study; MVD is cytosolic in fibroblasts, liver,
      CV1 and HEK293 cells by fractionation, immunofluorescence and immunoelectron
      microscopy.
    supported_by:
    - reference_id: PMID:14972328
      supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
core_functions:
- description: >-
    ATP-dependent decarboxylation of (R)-5-diphosphomevalonate
    (mevalonate-5-diphosphate) to isopentenyl diphosphate (IPP), CO2, ADP and
    phosphate, the final step of the mevalonate pathway that generates the
    universal C5 isoprenoid unit.
  molecular_function:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  directly_involved_in:
  - id: GO:0019287
    label: isopentenyl diphosphate biosynthetic process, mevalonate pathway
  supported_by:
  - reference_id: PMID:18823933
    supporting_text: "Mevalonate diphosphate decarboxyase (MDD1; EC 4.1.1.33) catalyzes the ATP dependent decarboxylation of mevalonate 5-diphosphate (MVAPP) to form isopentenyl 5-diphosphate"
  - reference_id: file:human/MVD/MVD-uniprot.txt
    supporting_text: "Catalyzes the ATP dependent decarboxylation of (R)-5-"
- description: >-
    As the terminal mevalonate-pathway enzyme, MVD supplies IPP for the broader
    isoprenoid biosynthetic program (sterols and non-sterol isoprenoids), acting
    as a soluble cytosolic enzyme.
  molecular_function:
    id: GO:0004163
    label: diphosphomevalonate decarboxylase activity
  directly_involved_in:
  - id: GO:0008299
    label: isoprenoid biosynthetic process
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: PMID:18823933
    supporting_text: "The reaction is required for production of polyisoprenoids and sterols from acetyl-CoA."
  - reference_id: PMID:14972328
    supporting_text: "We found a\ncytosolic localization for both endogenous human mevalonate pyrophosphate\ndecarboxylase"
proposed_new_terms: []
suggested_questions:
- question: >-
    Beyond its metabolic role, does the MVD-mortalin (HSP70) interaction have a
    regulatory function on MVD stability or activity, or is it primarily relevant
    to mortalin-controlled proliferation?
suggested_experiments:
- description: >-
    Structure-guided kinetic characterization of the full panel of POROK7 missense
    variants to quantify how each affects diphosphomevalonate decarboxylase
    activity and homodimer stability, correlating biochemical severity with
    clinical presentation.